Akari Therapeutics (AKTX) Shareholder's Equity Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.58% |
| Sep 30, 2025 | 26.70% |
| Jun 30, 2025 | 33.86% |
| Mar 31, 2025 | 46.08% |
| Dec 31, 2024 | 393.45% |
| Sep 30, 2024 | -27.47% |
| Jun 30, 2024 | -58.68% |
| Mar 31, 2024 | -22.28% |
| Dec 31, 2023 | -15.47% |
| Sep 30, 2023 | -72.23% |
| Jun 30, 2023 | -34.42% |
| Mar 31, 2023 | 102.74% |
| Dec 31, 2022 | -39.58% |
| Jun 30, 2022 | -18.29% |
| Mar 31, 2022 | -9.06% |
| Dec 31, 2021 | -30.44% |
| Sep 30, 2021 | -22.65% |
| Jun 30, 2021 | -47.70% |
| Mar 31, 2021 | -38.93% |
| Sep 30, 2020 | -30.00% |
| Jun 30, 2020 | 43.68% |
| Mar 31, 2020 | 4.72% |
| Dec 31, 2019 | -67.88% |
| Jun 30, 2019 | -46.43% |
| Dec 31, 2018 | 61.25% |
| Dec 31, 2017 | 53.84% |
| Dec 31, 2016 | 73.50% |